Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × tisotumab vedotin × 30 days × Clear all

Phase

Status

Active not recruiting 2 Recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Uterine Cervical Neoplasms 1

Interventions

Specimen Handling 191 pembrolizumab 163 Magnetic Resonance Spectroscopy 153 Biopsy 114 Carboplatin 109 Cisplatin 91 Cyclophosphamide 84 Paclitaxel 75 venetoclax 69 Bevacizumab 67 Nivolumab 63 Gemcitabine 63 Radiotherapy 53 Dexamethasone 52 Rituximab 49 Pemetrexed 48 fludarabine 46 Oxaliplatin 43 Fluorouracil 42 Doxorubicin 38 Docetaxel 37 Capecitabine 36 atezolizumab 35 Cetuximab 35 Prednisone 33 Leucovorin 33 Azacitidine 33 durvalumab 32 X-Rays 32 130-nm albumin-bound paclitaxel 31

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06459180 2026-03-13

TroFuse-020

Merck Sharp & Dohme LLC

Phase 3 Recruiting

Uterine Cervical Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡